At Cellen Therapeutics we are inspired by the stories of the patients we help
Cellen Therapeutics is an independent, UK-based company working with industry partners to ensure patients receive products compliant with EU GACP, EU GMP and EU GDP standards.
Meet the Team
Chief Executive Officer
Dr Benjamin Viaris de Lesegno MD, MSc
Chief Medical Officer & NHS Doctor
Dr Haggai Sharon MD, PhD
Chairman of Clinical Board & NHS Doctor
Cellen is one of the founding partners of the leading Medical Cannabis Project Twenty21, overseen by DrugScience.
Project Twenty21 will be the largest European observational registry of patients taking prescribed Cannabis-based Medicinal Products.
We will be aiming to enrol 20,000 UK patients over the next 2 years to understand safety and efficacy of Medical Cannabis. As a UK-based, independent company, we are thrilled at Cellen to be continuing our mission of improving the health of people living with chronic conditions
“As a science-led company, Cellen is proud to participate in Europe’s largest Medical Cannabis research project, to further our understanding of the efficacy of cannabis-based medical products and provide a substantial evidence base which we hope will shape the future of Medical Cannabis treatment in the UK.”
– Dr Benjamin Viaris de Lesegno MD MSc
Co-Founder & Chief Medical Officer of Cellen